StockData
Revelation Biosciences, Inc. logo

Revelation Biosciences, Inc. (REVB) stock

REVBNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as REVBW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$3.50−0.19 (-5.15%)

Close on Nov 20, 2026Market cap $13.94MP/E –Yield –

Revelation Biosciences gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

No gross profit figures for Revelation Biosciences

Revelation Biosciences has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Revelation Biosciences figures

See a number that looks wrong?